Author of the publication

A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells

, , , , , , , and . Frontiers in Pharmacology, (2020)
DOI: 10.3389/fphar.2020.00686

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor, , , , and . Glia, 62 (2): 272--283 (February 2014)Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules, , , , and . Antibodies, 11 (2): 34 (2022)EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells, , , , , , , , , and . PLOS ONE, 9 (9): e107165 (2014)EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells, , , , , , , , , and . PLoS ONE, 9 (9): e107165 (September 2014)Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma, , , , , , , , , and 16 other author(s). Clinical Cancer Research, 25 (7): 2228-2240 (2019)PBPK Modeling to Guide Experimental Design in Drug Development, , , , , , , , and . The American Conference on Pharmacometrics 2015 (ACoP6), 42, Suppl. 1, page S75. Dordrecht, Springer, (2015)PBPK-PD Modeling to provide a translational rationale between drugs and between species: example of trail fusion proteins, , , , , , , , , and . Abstracts / ASCPT 2016 Annual Meeting & Quantitative Translational Approaches in Oncology Pre-Conference, 99, Suppl. 1, page S70. Hoboken, NJ, Wiley-Blackwell, (2016)Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signaling, , , , , , , , , and 4 other author(s). Oncotarget, 7 (33): 53526-53539 (2016)A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells, , , , , , , and . Frontiers in Pharmacology, (2020)Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis, , , , , , , , , and 4 other author(s). Scientific Reports, (2018)